Old Web
English
Sign In
Acemap
>
authorDetail
>
Rae Ann Ruck
Rae Ann Ruck
Merck & Co.
Internal medicine
Endocrinology
Medicine
Laropiprant
Cholesterol
4
Papers
83
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes
2016
Lipids in Health and Disease
Eliot A. Brinton
Joseph Triscari
Philippe Brudi
Erluo Chen
Amy O. Johnson-Levonas
Christine McCrary Sisk
Rae Ann Ruck
Alexandra MacLean
Darbie Maccubbin
Yale B. Mitchel
Show All
Source
Cite
Save
Citations (3)
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.
2015
Vascular Health and Risk Management
Harold E. Bays
Eliot A. Brinton
Joseph Triscari
Erluo Chen
Darbie Maccubbin
Alexandra MacLean
Kendra L Gibson
Rae Ann Ruck
Amy O. Johnson-Levonas
Edward A. O'Neill
Yale B. Mitchel
Show All
Source
Cite
Save
Citations (4)
Effects of Extended-release Niacin/Laropiprant on Apolipoprotein B, LDL-Cholesterol, and Non-HDL-cholesterol Targets in Patients with Type 2 Diabetes
2012
Journal of Clinical Lipidology
Joseph Triscari
Erluo Chen
Amy O. Johnson-Levonas
Yale B. Mitchel
Rae Ann Ruck
Alexandra MacLean
Darbie Maccubbin
Show All
Source
Cite
Save
Citations (1)
Efficacy and safety of the selective 11β-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertension.
2011
Journal of The American Society of Hypertension
Sukrut Shah
Anne Hermanowski-Vosatka
Kendra L Gibson
Rae Ann Ruck
Gang Jia
John Zhang
Peggy Hwang
Nicholas W. Ryan
Ronald B. Langdon
Peter U. Feig
Show All
Source
Cite
Save
Citations (75)
1